Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ImmunityBio
ImmunityBio is a clinical-stage immunotherapy biotech based in California.
Marketing
ImmunityBio hit with FDA warning letter over Anktiva promotions
The FDA issued a warning letter to ImmunityBio regarding promotional statements about Anktiva that the agency claims are “false or misleading.”
Andrea Park
Mar 24, 2026 1:15pm
FDA chides BeOne, ImmunityBio in separate untitled letters
Jan 15, 2026 11:50am
ImmunityBio's Anktiva hits the mark in bladder cancer subtype
Dec 17, 2025 9:35am
GSK's long-acting asthma med wins CHMP backing
Dec 12, 2025 11:27am
J&J puts ImmunityBio on defense mode in bladder cancer
Apr 27, 2025 12:35pm
ImmunityBio, SII win FDA nod to help combat BCG shortage
Feb 19, 2025 9:01am
